Page 329 - Williams Hematology ( PDFDrive )
P. 329

304            Part IV:  Molecular and Cellular Hematology                                                                                                                                 Chapter 20:  Innate Immunity            305




                                                                                                129
               protein antigen in guinea pigs infected with Mycobacterium tuberculosis.     mutations affecting IFN-γ,  IL-12  and its receptor, 130,131  defects of
                                                                                          128
                                 115
                                                                                    132
               Freund and McDermott  demonstrated that heat-killed mycobacteria   granule formation,  and defects of nicotinamide adenine dinucleotide
               were capable of eliciting an exaggerated antibody response as well when   phosphate (NADPH) oxidase. 133
               coadministered with a protein antigen, indicating that molecular com-
               ponents of microbes (rather than infection per se) were responsible for
               adjuvanticity. LPS was shown to be endowed with adjuvant activity in     THE GENERAL STRATEGY OF INNATE
                   116
               1955,  and by 1975 the Lps locus was shown to be required for this   IMMUNE RESPONSES AND THE
                                                               117
               effect of LPS (as it is required for all other cellular effects of LPS).  By
               deduction, the positional cloning of Lps thus revealed the essential role   CONCEPT OF FORWARD FEEDBACK
               of TLR4 in LPS-mediated adjuvanticity. 7
                   Activation of an adaptive immune response to a specific anti-  LOOPS IN AUTOIMMUNITY
               gen has long been known to depend upon two signals that occur in   Although the term “autoimmunity” is reserved for inappropriate adap-
               the course of antigen presentation. First, the T-cell receptor must be    tive  immune responses that damage tissues of  the host, the innate
               activated. In addition, costimulatory molecules upregulated on the     immune system may also cause injury or death, and typically does so
               antigen-presenting cell (e.g., CD40, CD69, CD80, and CD86) are known   when systemic activation occurs in the course of a serious infection.
               to interact with receptors (or in some cases ligands) on the T cell. An   Innate immune responses, which entail cytokine-mediated inflamma-
               exchange of signals occurs over a period of approximately 12 hours,    tion and coagulation, evolved to contain small inoculates of microor-
                                                                 118
               ultimately leading to autonomous expansion of the T-cell clone and, in   ganisms by encouraging the influx of granulocytes to engulf and destroy
               turn, activation of specific B cells. Some of these signals are well charac-  these pathogens, and by stimulating the development of an adaptive
               terized. For example, CD80 and CD86 both engage CD28 and cytotoxic   immune response. The mechanisms that are employed to these ends can
               T-lymphocyte antigen (CTLA) on the T-cell surface, and abrogation of   be lethal if they are generalized rather than focal. In several examples,
               signaling via these costimulatory  receptors  is known  to substantially   the importance of microbes as drivers of inflammation has been cited,
               attenuate the adaptive immune response. 119            and forward-feedback loops may perpetuate inflammation or auto-
                   Upregulation  of  costimulatory  molecules  (UCM)  is  therefore   immunity. It has been reported, for example, that endogenous DNA,
               essential, although not by itself sufficient, for activation of the adap-  signaling via TLR9, is responsible for the generation and perpetuation
               tive immune response. LPS depends upon TRIF (and specifically, upon   of antinucleoprotein antibodies in a mouse model of systemic lupus
               TRIF-mediated type I IFN gene expression) to elicit UCM 42,60,120 ; absent   erythematosus.  The involvement of TLRs 3 and 7 may also be
                                                                                 134
               TRIF, LPS cannot exert an adjuvant effect. TRAM is also required for   important.
                    41
               UCM.  Although MyD88 does not elicit UCM, it does contribute to   In hemophagocytic lymphohistiocytosis (HLH), an amplification
                                                      60
               LPS-induced adjuvanticity in an experimental setting.  It is likely that   loop involving a microbial driver, CTL expansion, and IFN-γ driven
               IL-12, a cytokine that is largely MyD88-dependent, also contributes to   myeloid expansion has been well described in mice.  In SHP1 defi-
                                                                                                             135
               the adjuvant effect, along with other proteins yet to be identified.  ciency in mice, autoimmunity and inflammation also depend upon a
                   Even  though  several  publications  initially  suggested  that TLR   microbial driver and activation of TIR domain signaling pathways.
                                                                                                                       136
               signaling is required for adaptive immune responses to occur, it has   NOMID and other mutations capable of activating the NLRP3 inflam-
               been observed that mice lacking all TLR signaling are quite capable of   masome have been mentioned earlier in this chapter. Beyond this, the
               mounting adaptive immune responses, including antibody responses   innate immune system may also contribute to sterile inflammation
               and recall responses to defined antigens administered with diverse     (autoinflammatory disease), as witnessed in many human diseases that
               adjuvants.  It is now evident that there is much redundancy in adaptive   have so far eluded etiologic decipherment.
                       121
               immune responses, and several innate immune pathways can indepen-
               dently trigger such responses.
                                                                      REFERENCES
                    DISEASES CAUSED BY INNATE                           1.  Pancer Z, Amemiya CT, Ehrhardt GR, et al: Somatic diversification of variable lympho-
                                                                         cyte receptors in the agnathan sea lamprey. Nature 430:174, 2004.
                  IMMUNE DEFECTS                                        2.  Cooper MD, Alder MN: The evolution of adaptive immune systems. Cell 124:815, 2006.
                                                                        3.  Pfeiffer R: Untersuchungen über das Choleragift. Z Hyg Infektionskr 11:393, 1892.
               Premature death from infection is strongly heritable in humans.      4.  Raetz CR, Whitfield C: Lipopolysaccharide endotoxins.  Annu Rev  Biochem 71:635,
                                                                 122
               Defects of the innate immune sensing apparatus are expected to cause   2002.
               hypersusceptibility to infection in humans as they clearly do in mice,     5.  Galanos C, Luderitz O, Rietschel ET, et al: Synthetic and natural Escherichia coli free
                                                                         lipid A express identical endotoxic activities. Eur J Biochem 148:1, 1985.
               and specific examples of such mutations have recently come to light     6.  Rosenstreich DL, Weinblatt AC, O’Brien AD: Genetic control of resistance to infection
               including the NLR disorders discussed above (see “Sensors of the   in mice. CRC Crit Rev Immunol 3:263, 1982.
               NOD-Like Receptor Family”). Missense mutations of TLR4 that are     7.  Poltorak A, He X, Smirnova I, et al: Defective LPS signaling in C3H/HeJ and
                                                                         C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085, 1998.
               rare among the normal white population are quite common in patients     8.  Anderson KV, Bokla L, Nusslein-Volhard C: Establishment of dorsal-ventral polarity in
               with systemic meningococcal disease, and have been assigned a role in   the Drosophila embryo: The induction of polarity by the Toll gene product. Cell 42:791,
                                   123
               susceptibility on this basis.  A nonsense mutation of TLR5 was found   1985.
               to be overrepresented in patients who developed Legionnaire disease     9.  Lemaitre B, Nicolas E, Michaut L, et al: The dorsoventral regulatory gene cassette spätzle/
                                                                         Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973,
               as compared to a comparably exposed population that remained dis-  1996.
                      124
               ease-free.  Mutations of IRAK4 and MyD88 create susceptibility to     10.  Hemmi H, Takeuchi O, Kawai T, et al: A Toll-like receptor recognizes bacterial DNA.
                                                                         Nature 408:740, 2000.
               suppurative Gram-positive infections. 44,125  In humans, both TLR3  and     11.  Takeuchi O, Kaufmann A, Grote K, et al: Preferentially the R-stereoisomer of the
                                                              126
                       127
               UNC93B1  mutations cause susceptibility to recurrent Herpes simplex   mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells
               virus encephalitis, and presumably to other diseases as well.  through a Toll-Like receptor 2- and MyD88-dependent signaling pathway. J Immunol
                   On the effector side, examples of immunocompromise from innate   164:554, 2000.
               immune defects are far better known, and include diseases caused by     12.  Takeuchi O, Sato S, Horiuchi T, et al: Cutting edge: Role of Toll-like receptor 1 in medi-
                                                                         ating immune response to microbial lipoproteins. J Immunol 169:10, 2002.



          Kaushansky_chapter 20_p0293-0306.indd   304                                                                   9/17/15   5:52 PM
   324   325   326   327   328   329   330   331   332   333   334